Robert E. Landry
2013
In 2013, Robert E. Landry earned a total compensation of $12.6M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $11,054,274 |
| Salary | $144,231 |
| Stock Awards | $1,363,500 |
| Other | $1,130 |
| Total | $12,613,135 |
Landry received $11.1M in option awards, accounting for 88% of the total pay in 2013.
Landry also received $50K in bonus, $144.2K in salary, $1.4M in stock awards and $1.1K in other compensation.
Rankings
In 2013, Robert E. Landry's compensation ranked 248th out of 12,286 executives tracked by ExecPay. In other words, Landry earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 248 out of 12,286 | 98th |
Division Manufacturing | 79 out of 4,612 | 98th |
Major group Chemicals And Allied Products | 21 out of 1,462 | 99th |
Industry group Drugs | 14 out of 1,156 | 99th |
Industry Pharmaceutical Preparations | 12 out of 890 | 99th |
Source: SEC filing on April 26, 2016.
Landry's colleagues
We found five more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2013.
2013
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2013
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2013
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2013
Robert Terifay
Regeneron Pharmaceuticals
Executive Vice President, Commercial
2013
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019